RE 1492
| Code | Size | Price |
|---|
| TAR-T26052-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
| TAR-T26052-50mg | 50mg | £1,661.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
| TAR-T26052-100mg | 100mg | £2,079.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
RE 1492 is an oligoamine that gives it an antiplatelet effect when combined with antithrombic drugs.
CAS:
112169-14-9
Formula:
C39H51N3
Molecular Weight:
561.858
Purity:
0.98
SMILES:
C(CCc1ccccc1)CNCc1cc(CNCCCCc2ccccc2)cc(CNCCCCc2ccccc2)c1
References
1. Rehse K, Ciborski T. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XXVI: Antiplatelet and antithrombotic effects of the oligoamine RE 1492 in combination with standard and future antithrombotic drugs. Arch Pharm (Weinheim). 1995 Apr;328(4):333-7. PubMed PMID: 7611829.
2. Kesselhut A, Ebel H, von Bruchhausen F, Rehse K. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XXV: Interactions of the oligoamine RE 1492 with biomembranes. Arch Pharm (Weinheim). 1995 Jan;328(1):21-7. PubMed PMID: 7695469.
3. Rehse K, M?ller S. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XXIX: Influence of the antithrombotic oligoamine RE 1492 on the storage of red blood cells, morphology, their potassium and ATP content, hemolysis and viability. Arch Pharm (Weinheim). 1995 Apr;328(4):339-42. PubMed PMID: 7611830.
4. Neumann M, M?ller S, Grosse J, Lerche D, Rehse K. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XXIII: Influence of the oligoamine RE 1492 on the deformability of red blood cells. Arch Pharm (Weinheim). 1994 Aug;327(8):497-501. PubMed PMID: 7944905.